Harvind Chahal is a Dermatology physician affiliated with Stanford Medicine. OpenAlex indexes 19 publications with 531 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Galderma Laboratories, L.P.Program year20252 payments
- LEO Pharma Inc.Program year20251 payment
- GENZYME CORPORATIONProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
39.3%Corticosteroid39.3%Clobetasol Propionate56%Betamethasone Diprop Augmented24%Hydrocortisone20%Part D≥83 patientsDermatology
21.7%Corticosteroid18.2%Triamcinolone Acetonide100%Part D≥88 patientsInterleukin-4 Receptor alpha Antagonist3.5%Dupixent Pen52%Dupixent Syringe48%Part D<11 patientsAnti-infectives
18.9%Azole Antifungal10.6%Ketoconazole100%Part D≥39 patientsTetracycline-class Drug3.1%Doxycycline Hyclate100%Part D≥15 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Incidence ratio of basal cell carcinoma to squamous cell carcinoma equalizes with age
Journal of the American Academy of Dermatology
2017 - Correlates of multiple basal cell carcinoma in a retrospective cohort study: Sex, histologic subtypes, and anatomic distribution
Journal of the American Academy of Dermatology
2017 - Association study of genetic variation in DNA repair pathway genes and risk of basal cell carcinoma
International Journal of Cancer
2017 - Association between genetic variation within vitamin D receptor‐DNA binding sites and risk of basal cell carcinoma
International Journal of Cancer
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Jeffrey Teuteberg, MD
Stanford Medicine
Charles Debattista, MD
Stanford Medicine
Jong Yoon, MD
Stanford Medicine
Kimberly Dequattro, MD, MM
Stanford Medicine
Bridget Grant, MD
Bassett Medical Center
Robert Modlin, MD
University of California, Los Angeles
Andrew Blauvelt, MD
University of Maryland School of Medicine
Howard Maibach, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”